Latus Bio
Philadelphia, PA
Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing.
latusbio.comCompany Details
Founded
- 2022
Employees
- Between 10 - 50 employees
Raised
- $54,000,000
Headquarters Location
- Philadelphia, PA
Public
- No
Acquired
- No
CEO
Paiman Peter Ghoroghchian
Company Collections
These are collections Latus Bio is a part of. Click on the collection name to view similar companies.